Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
Correspondence Show SomaLogic Failed to Engage with Labcorp – One of the Industry’s Leading Strategics, with a $19 Billion Market Cap – Prior to Pursuing Standard BioTools Deal Madryn Will...